INNOVATE Corp.
INNOVATE Corp. Q4 FY2025 earnings call
March 26, 2026 · fiscal period ended 2025-12
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2026-03-26
Management highlights
- Paul Voigt reported fourth quarter and full year 2025 financial results, and provided update on three operating segments.
- DBM Global had fourth quarter revenues of $373.9 million and adjusted EBITDA of $28 million, full year 2025 revenue of $1.2 billion and adjusted EBITDA of $87.5 million, with backlog increase and positive momentum in New York City market.
- MetaBeacon had FDA approval of next gen TGFR system, peer-reviewed article selected as Editor's Choice, and early commercialization in China and launch of Center of Excellence Sales Initiative in U.S.
- R2 had fourth quarter 2025 revenues of $3.1 million (vs $4.1 million prior year), full year 2025 revenue of $12.5 million (28% increase y-o-y), with international market progress including restructured distribution agreement in China and regained distribution rights in Asian Pacific markets.
- Spectrum had fourth quarter 2025 revenue of $5.7 million and adjusted EBITDA of $1 million, with new network launches like RAV en Español and Heartland Network, joint venture trials, and FCC developments for Spectrum expansion.
Segment performance
For the fourth quarter, Innovate delivered consolidated revenues of $382.7 million and adjusted EBITDA of $24.5 million. For the full year 2025, consolidated revenues were $1.2 billion and adjusted EBITDA of $67.2 million.
Infrastructure (DBM Global): Fourth quarter revenues of $373.9 million and adjusted EBITDA of $28 million. Full year 2025 revenue of $1.2 billion and adjusted EBITDA of $87.5 million. Gross margin compression of approximately 350 basis points to 14.7% and adjusted EBITDA margin compression of approximately 20 basis points to 7.5% year-over-year. Adjusted backlog increased by approximately $700 million to just over $1.8 billion since end of 2024.
Life Sciences: MetaBeacon achieved FDA approval of next generation TGFR system, had peer-reviewed article selected as 2025 Editor's Choice. R2 reported fourth quarter 2025 revenues of $3.1 million (vs $4.1 million prior year), full year 2025 revenue of $12.5 million (28% increase y-o-y). International markets saw 123% top-line revenue increase and 187% gross system unit sales increase. Backlog of approximately 80 units globally.
Spectrum: Fourth quarter revenue of $5.7 million and adjusted EBITDA of $1 million. Year-over-year revenue decreased $1.1 million and adjusted EBITDA decreased $1.3 million. Soft advertising environment, but new network launches starting, joint venture with mobile wireless carrier, FCC developments creating opportunity to expand U.S. Spectrum footprint.
Risks
Forward-looking statements involve risks, assumptions, and uncertainties, subject to risk factors that could cause actual results to differ materially from forward-looking statements. Risk factors more fully discussed in earnings release, slide presentation, 10-K and other SEC filings.
Q&A highlights
There are no questions in the question and answer session as indicated by 'There are no questions at this time'
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $-0.58 | $-2.18 | +73.4% | $-1.29 |
| Revenue | $382.7M | $251.7M | +52.0% | $236.6M |
Transcript
March 26, 2026Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.